Portfolio Category: Current

Ventyx Biosciences

Ventyx Biosciences

Developing selective inhibitors of TYK2 for autoimmune diseases.

Read More
Morrow

Morrow

Focused on the commercialization of spectacles with digital lens technology.

Read More
DUST Identity

DUST Identity

Utilizes diamond crystals to enable secure identification of physical objects.

Read More
Isorg

Isorg

Focused on developing an organic photodetector material (OPD) for several commercial applications.

Read More
PlanetIQ

PlanetIQ

Focused on generating higher quality atmospheric data through the design of a new satellite-deployed instrument.

Read More
ChromaCure

ChromaCure

Focused on the development of a first-in-class oncology therapeutic.

Read More
NorthSea Therapeutics

NorthSea Therapeutics

Focused on the development of first-in-class therapeutics for NASH and other metabolic, inflammatory and fibrotic diseases.

Read More
Vascular Therapies

Vascular Therapies

Focused on the development of a drug-based solution to reduce the failure rate of AV Fistulas in dialysis patients.

Read More
Trellis Bioscience

Trellis Bioscience

Developer of CellSpot platform to derive therapeutic antibodies directly from the human immune system.

Read More
Svelte Medical Systems

Svelte Medical Systems

Developer of a radial drug-eluting stent platform to simplify cardiovascular stenting procedures.

Read More
Resolve Therapeutics

Resolve Therapeutics

Focused on the development of a biologic therapy for Lupus and Sjögren’s Syndrome.

Read More